euro adhoc: Marseille-Kliniken AG / other / - Another substantial sale-and-lease-back transaction closed - Sales of 3 care and 3 rehabilitation facilities with a total real estate value of EUR 95.5 mi

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

29.06.2007

Berlin, June 29, 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE
0007783003, MKA) successfully closed a third substantial
sale-and-lease-back transaction with real estate investor Grosvenor
House Group PLC, Great Britain. To this end, Marseille-Kliniken AG
will sell a total of six properties - three care facilities and three
rehabilitation properties, totalling 1,304 beds to the British
investor by way of a sale-and-lease-back transaction and will
simultaneously lease all properties back from the company in the long
term.

The transaction with a total volume of EUR 95.5 million provides the
enterprise with expanded financial flexibility to realize its growth
strategy in core segment care. It must be emphasized that the largest
share in the transaction, more than 60%, comes from the
rehabilitation segment. The sales revenues generated from the
rehabilitation segment thus accounts for more than 90% of the balance
sheet book value of the entire rehabilitation segment, marking the
first increase of inner reserves in this sector.

After the implementation of the transaction, the real estate
portfolio of the Marseille-Kliniken AG will be divided into
approximately 20% owned and 80% leased facilities. The transaction
will further reduce the long term financial debts of the enterprise.

End of adhoc release

end of announcement euro adhoc 29.06.2007 07:27:47
--------------------------------------------------------------------------------

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
If you have any questions, please contact:
Marseille-Kliniken AG
Axel Hölzer
CEO
Alte Jakobstraße 79/80
10709 Berlin, Germany
Tel.: +49-30 / 246 32-400
Fax: +49-30 / 246 32-401
www.marseille-kliniken.com

or

Hillermann Consulting
Christian Hillermann
Investor Relations Marseille-Kliniken AG
Eppendorfer Baum 5
20249 Hamburg
Germany
Tel.: +49-40 / 414 069-13
Fax: +49-40 / 414 069-14
www.hillermann-consulting.com

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hamburg / official dealing